Antiskin Autoantibodies, Quantitative
Also known as: Cutaneous Immunofluorescence, Indirect
Use
Detect the presence of circulating pemphigus and bullous pemphigoid antibodies in sera. Intracellular antibodies are present in 85% to 90% of pemphigus patients and specific basement membrane antibodies are present in 70% to 80% of patients with bullous pemphigoid.
Special Instructions
The test employs an indirect fluorescent antibody (IFA) methodology. Specimens should be collected using a red-top tube or gel-barrier tube and maintained at room temperature.
Limitations
Results could be affected by bacterial contamination or lipemia in the specimen. Turnaround time may vary based on the need for additional confirmatory or reflex tests.
Methodology
Immunoassay (Indirect fluorescent antibody (IFA))
Biomarkers
LOINC Codes
- 5152-4
- 5152-4
Result Turnaround Time
2-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.4 mL
Minimum Volume
0.2 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Maintain specimen at room temperature.
Causes for Rejection
Bacterial contamination; lipemia